• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Ontrak Selects Mary Louise Osborne as Company's First Chief Customer Officer

    8/10/21 8:00:00 AM ET
    $CVS
    $OTRK
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Misc Health and Biotechnology Services
    Health Care
    Get the next $CVS alert in real time by email

    Osborne brings proven track record of leadership in growth and expansions of multi-billion dollar government and commercial businesses at CVS Health, Aetna and Coventry Health Care

    Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of former CVS Health (NYSE:CVS) Regional Vice President and former President of Government business at Coventry Health Care Mary Louise Osborne as Ontrak's first Chief Customer Officer, effective August 30, 2021. Ms. Osborne will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS in April.

    "Mary Lou brings decades of progressive management experience and a proven track record of driving accelerated growth, expansion and operational performance in both commercial and government businesses," said Jonathan Mayhew, Ontrak CEO. "She has built deep, trusted partnerships with customers, government leaders and health care providers. I'm delighted that Mary Lou will be joining the Ontrak leadership team at a time when Medicaid and Medicare represent an increasing share of our revenues. In her new role she will be responsible for our current portfolio of customers, all new customer sales, and the Ontrak customer implementation and vendor management office."

    Ms. Osborne stated, "I am thrilled to be joining Ontrak, an innovative, purpose-driven company focused on improving health and saving lives. Jonathan's vision and focus for the organization as a customer-centric enterprise attracted me to this role, and I very much want to help expedite his growth plan."

    As Regional Vice President, Medicaid, East Region at CVS Health, Osborne tripled Medicaid revenue to $4 Billion and grew the membership to 800,000 members by winning 12 new and renewal State Medicaid contracts and implementing new multi-state product expansions for Medicaid, Children's Health Insurance Program (CHIP), Managed Long Term Services and Supports (MLTSS) and Foster Care. Previously, she was President of Government business at Coventry Health Care, where she led the largest government plan expansion in the health plan's history, boosting Medicare Advantage and Individual membership growth by 30% annually. Osborne also achieved 20% annual commercial growth and attained an excellent NCQA accreditation for quality and compliance. Prior to joining Coventry Health Care, Osborne was the General Manager responsible for Commercial business membership, financial growth and operations for Aetna's Southeast region.

    About Ontrak, Inc.

    Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company's integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.

    Learn more at www.ontrakhealth.com

    Cautionary Note Regarding Forward-Looking Statements

    Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. Forward looking statements may include statements regarding our proprietary IP and technological innovation allowing us to identify, engage, and create lasting behavior change in the lives of those with unaddressed behavioral health conditions and chronic disease. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210810005126/en/

    Get the next $CVS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $OTRK

    CompanyDatePrice TargetRatingAnalyst
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    CVS Health Corporation
    $CVS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    CVS Health Corporation
    $CVS
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    CVS Health Corporation
    $CVS
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    CVS Health Corporation
    $CVS
    1/30/2025Hold → Buy
    Edward Jones
    CVS Health Corporation
    $CVS
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    CVS Health Corporation
    $CVS
    11/18/2024$60.00 → $66.00Equal Weight → Overweight
    Wells Fargo
    CVS Health Corporation
    $CVS
    10/10/2024$63.00 → $82.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $CVS
    $OTRK
    SEC Filings

    View All

    SEC Form 144 filed by CVS Health Corporation

    144 - CVS HEALTH Corp (0000064803) (Subject)

    8/19/25 6:57:22 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form NT 10-Q filed by Ontrak Inc.

    NT 10-Q - Ontrak, Inc. (0001136174) (Filer)

    8/15/25 6:36:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    8/15/25 4:10:49 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $OTRK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Peizer Terren S exercised 500,000 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/24/25 6:32:14 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/23/25 8:06:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Park James J converted options into 4 shares and covered exercise/tax liability with 1 shares, increasing direct ownership by 33% to 12 units (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/17/25 5:33:52 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $CVS
    $OTRK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

    Financial Highlights Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior yearSecond quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81Generated year-to-date cash flow from operations of $6.5 billionOperational Highlights Aetna® delivers distinctive advances in care navigationCVS Pharmacy® agreed to acquire certain prescription files and store locations from Rite AidCVS Caremark® demonstrates market-leading innovation in strong renewal and sales season2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $3.84 to $3.94 from $4.23 to $4.43Raised Adjusted EPS guidance range to $6.30 to $6.40 from $6.00 to $6.20Raised cash flow from operation

    7/31/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna Launches New AI and Digital Tools to Improve Access and Care

    Aetna Care Paths, a first-to-market care option available in the Aetna Health app, makes it easier and simpler for members to get the care they needAI enabled clinical solutions enhance the human touch, giving nurses 90 more minutes a day to spend with membersWOONSOCKET, R.I., July 29, 2025 /PRNewswire/ -- To make the health care system easier to navigate, Aetna, a CVS Health® company (NYSE:CVS), today announced the introduction of Aetna Care Paths and AI-driven programs as part of the company's ongoing technology investment to improve the experience for medical professionals and their patients.

    7/29/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners

    NEW YORK, July 21, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the electronic data interchange (EDI) market is observing significant growth owing to the rising digital transformation across various industries and the growing adoption of EDI in small and medium enterprises. The electronic data interchange market was valued at US$34.02 billion in 2024 and is projected to reach US$74.36 billion by 2031; it is expected to register a CAGR of 11.9% during 2025-2031.  The electronic data interchange market comprises an array of components a

    7/21/25 11:30:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $CVS
    $OTRK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    2/19/25 12:35:35 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Ludwig Edward J bought $53,879 worth of shares (1,000 units at $53.88), increasing direct ownership by 5% to 21,630 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    5/2/24 4:31:44 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $OTRK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded CVS Health from Neutral to Outperform and set a new price target of $82.00

    8/14/25 8:02:24 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded CVS Health from Market Perform to Outperform and set a new price target of $75.00 from $55.00 previously

    2/13/25 7:04:02 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $OTRK
    Financials

    Live finance-specific insights

    View All

    CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

    Financial Highlights Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior yearSecond quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81Generated year-to-date cash flow from operations of $6.5 billionOperational Highlights Aetna® delivers distinctive advances in care navigationCVS Pharmacy® agreed to acquire certain prescription files and store locations from Rite AidCVS Caremark® demonstrates market-leading innovation in strong renewal and sales season2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $3.84 to $3.94 from $4.23 to $4.43Raised Adjusted EPS guidance range to $6.30 to $6.40 from $6.00 to $6.20Raised cash flow from operation

    7/31/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2025, to holders of record on July 22, 2025. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, the Company had more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care me

    7/7/25 9:39:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health to hold second quarter 2025 earnings conference call

    WOONSOCKET, R.I., June 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Thursday, July 31st, 2025, at 8:00 a.m. ET to discuss second quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, th

    6/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $OTRK
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

    WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

    4/8/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Foundation helps address barriers to care and provides resources for individuals with chronic health conditions in Hartford

    Foundation announces $2 million in new Health Zones funding to support at-risk populations WOONSOCKET, R.I., March 6, 2025 /PRNewswire/ -- The CVS Health® Foundation today announced $2 million in new Health Zones funding to support the Hispanic Health Council's Family Wellness Center and its agency partners, all located in Hartford, Connecticut. This funding will help address critical gaps in the health care and social system for individuals with chronic health conditions by increasing access to comprehensive health care services and resources. "A variety of interconnected fac

    3/6/25 8:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health announces Pharmacy and Consumer Wellness leadership appointments

    WOONSOCKET, R.I., Dec. 3, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group president, CVS Health. In addition, the company announced the appointment of Lucille Accetta, RPh, MPH, MBA as chief pharmacy officer, also reporting to Shah. Both appointments are effective immediately. As president, Pharmacy and Consumer Wellness, Shankman will oversee the front store and retail pharmacy businesses across the company's more than 9,000 CVS Pharmacy locations. In his new

    12/3/24 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $OTRK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ontrak Inc.

    SC 13G/A - Ontrak, Inc. (0001136174) (Subject)

    11/14/24 4:24:03 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    10/3/24 6:37:08 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care